Unit:
|
Gudong Sub-district Office
|
![]() |
Project Area:
|
Fuzhou Gulou District
|
|
Industry:
|
Biological and New Pharmaceutical Industry
|
|
Type of Project:
|
New Project
|
|
Cooperation Mode:
|
Individual Proprietorship
|
|
Nature of Project:
|
Permit
|
|
Working Progress in Prior Period:
|
Meinian Onehealth Healthcare (Group) Co., Ltd., founded in 2004, is a chain operated organization integrating health examination, management and consultation, which is headquartered in Shanghai with over 100 health examination centers in nearly 50 major c
|
|
Total Investment:
|
100 million yuan
|
|
Expected to Attract Investment:
|
100 million yuan
|
Biological & New Pharmaceutical Industry
In 2020, the added value of industrial enterprises above designated size rose by 0.3 percent year on year, and the output value of the industry exceeded RMB 60 billion. The technology of such protein drugs as recombinant human granulocyte-macrophage colony-stimulating factor and its market share took the lead in China. In addition, bio-pharmaceutical technologies such as an Escherichia coli-derived virus-like particle-based vaccine, a recombinant hepatitis E vaccine, and a recombinant human papillomavirus vaccine all held world leading positions.